Joy Aho, Ph.D., discusses how Be The Match BioTherapies is harnessing the infrastructure and tools built for hematopoietic stem cell transplantation, an allogeneic cell therapy that has been used for decades to treat patients with blood cancers and disorders, to support the growth and commercialization of new allogeneic cellular therapies and help developers bring these emerging therapies to patients sooner.
.svg)
